FDA Inspection
Versiti Wisconsin, IncVersiti Wisconsin, Inc – FDA Inspection, Jun 16, 2016
Record Details
This FDA Inspection record concerns Versiti Wisconsin, Inc, with an inspection on June 16, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Versiti Wisconsin, Inc
- Inspection Date
- June 16, 2016
- Product Type
- Biologics
View Company Profile
ID · 45b70c6a-1703-4d3c-9588-959104df8cd9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 976252
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 610.40(b)One or more approved screening tests
- 21 CFR 630.10(e)(2)Additional Medical Assessment Factors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Versiti Wisconsin, Inc
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 17, 2026 | Not classified | Minneapolis District Office | |
| April 26, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 23, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 11, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 19, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Versiti Wisconsin, Inc
- FDA Inspection 1331502 - 2026-07-17
- FDA Inspection 1207882 - 2023-04-26
- FDA Inspection 1067700 - 2018-08-23
- FDA Inspection 1035583 - 2017-12-11
- FDA Inspection 896791 - 2014-09-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.